Faheem W Guirgis, MD, FACEP
Associate Professor; Program Director, Emergency Medicine & Acute Care Research Fellowship; Director, Center For Research Training
About Faheem W Guirgis
Faheem W. Guirgis, M.D., is an associate professor of emergency medicine at the University of Florida College of Medicine – Jacksonville. He received his medical degree from The Chicago Medical School at Rosalind Franklin University and his emergency medicine residency training at the Albert Einstein College of Medicine in New York City. He has served as a principal investigator of numerous observational and interventional studies of sepsis and septic shock.
His research program’s goal is to define the pathophysiologic role of lipids and lipoproteins in mediating organ failure, inflammation, and recovery from sepsis and to discover precision medicine treatments. He designed a Phase I and Phase II clinical trial testing the safety and efficacy of a lipid emulsion for stabilizing cholesterol levels in septic shock.
He has been the recipient of multiple NIH awards to fund his research, and is a past recipient of a Society of Critical Care Medicine Weil Research grant. He was also recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville, which has led to improved outcomes in patients admitted with sepsis, and received the Vizient Innovative Excellence Award in 2016.
Dr. Guirgis has also been a proponent of research education, and currently Directs the Center for Research Training at UF Jacksonville and is Co-director of the UF KL2 Program funded by NCATS.
Teaching Profile
Board Certifications
-
Emergency MedicineAmerican Board of Emergency Medicine
Clinical Profile
- Emergency Medicine
Research Profile
Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.
0000-0002-4445-3939
Publications
Grants
Education
Contact Details
- Business:
- (904) 244-4986
- Business:
- faheem.guirgis@jax.ufl.edu
- Business Mailing:
-
655 W 8TH ST FL 1
CLINICAL CENTER
JACKSONVILLE FL 32209 - Business Street:
-
655 W 8TH ST
JACKSONVILLE FL 32209